Tumor progression locus 2 (Map3k8) is critical for host defense against Listeria monocytogenes and IL-1β production

Journal of Immunology

Volumn 183, Issue 12, 2009, Pages 7984-7993

  Mielke, Lisa A ^a,b,c   Elkins, Karen L ^d   Wei, Lai ^a   Starr, Robyn ^e   Tsichlis, Philip N ^f   O'Shea, John J ^a   Watford, Wendy T ^a  

^a NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES   (United States)

^b WALTER AND ELIZA HALL INSTITUTE OF MEDICAL RESEARCH   (Australia)

^c UNIVERSITY OF MELBOURNE   (Australia)

^d CENTER FOR BIOLOGICS EVALUATION AND RESEARCH   (United States)

^e ST VINCENT'S INSTITUTE OF MEDICAL RESEARCH   (Australia)

^f TUFTS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CASPASE RECRUITMENT DOMAIN PROTEIN 15; INTERLEUKIN 1BETA; MITOGEN ACTIVATED PROTEIN KINASE KINASE KINASE; MITOGEN ACTIVATED PROTEIN KINASE KINASE KINASE 8; PATTERN RECOGNITION RECEPTOR; TOLL LIKE RECEPTOR 2; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; MAP3K8 PROTEIN, MOUSE; ONCOPROTEIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL TYPE; CONTROLLED STUDY; CORRELATION ANALYSIS; CYTOKINE PRODUCTION; DENDRITIC CELL; FEMALE; GENE MUTATION; HOST RESISTANCE; LISTERIA MONOCYTOGENES; LISTERIOSIS; MACROPHAGE; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; WILD TYPE; ANIMAL; BIOSYNTHESIS; C57BL MOUSE; CELL CULTURE; COMPARATIVE STUDY; DRUG ANTAGONISM; GENE EXPRESSION REGULATION; GENETIC TRANSDUCTION; GENETICS; IMMUNOLOGY; INNATE IMMUNITY; MOUSE MUTANT; PATHOGENICITY; PHYSIOLOGY;

ANIMALS; CELLS, CULTURED; FEMALE; GENE EXPRESSION REGULATION; IMMUNITY, INNATE; INTERLEUKIN-1BETA; LISTERIA INFECTIONS; LISTERIA MONOCYTOGENES; MALE; MAP KINASE KINASE KINASES; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; PROTO-ONCOGENE PROTEINS; SIGNAL TRANSDUCTION; TRANSDUCTION, GENETIC;

EID: 76249111625     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.0901336     Document Type: Article

References (60)

1. O'Neill, L. A. 2008. When signaling pathways collide: positive and negative regulation of toll-like receptor signal transduction. Immunity 29: 12-20.
2. Akira, S., S. Uematsu, and O. Takeuchi. 2006. Pathogen recognition and innate immunity. Cell 124: 783-801.
3. Ogura, Y., N. Inohara, A. Benito, F. F. Chen, S. Yamaoka, and G. Nunez. 2001. Nod2, a Nod1/Apaf-1 family member that is restricted to monocytes and activates NF-κB. J. Biol. Chem. 276: 4812-4818.
4. Girardin, S. E., I. G. Boneca, J. Viala, M. Chamaillard, A. Labigne, G. Thomas, D. J. Philpott, and P. J. Sansonetti. 2003. Nod2 is a general sensor of peptidoglycan through muramyl dipeptide (MDP) detection. J. Biol. Chem. 278: 8869-8872.
5. Inohara, N., Y. Ogura, A. Fontalba, O. Gutierrez, F. Pons, J. Crespo, K. Fukase, S. Inamura, S. Kusumoto, M. Hashimoto, et al. 2003. Host recognition of bacterial muramyl dipeptide mediated through NOD2: implications for Crohn's disease. J. Biol. Chem. 278: 5509-5512.
6. Inohara, N., Y. Ogura, F. F. Chen, A. Muto, and G. Nunez. 2001. Human Nod1 confers responsiveness to bacterial lipopolysaccharides. J. Biol. Chem. 276: 2551-2554.
7. Girardin, S. E., L. H. Travassos, M. Herve, D. Blanot, I. G. Boneca, D. J. Philpott, P. J. Sansonetti, and D. Mengin-Lecreulx. 2003. Peptidoglycan molecular requirements allowing detection by Nod1 and Nod2. J. Biol. Chem. 278: 41702-41708.
8. Brown, G. D., and S. Gordon. 2001. Immune recognition: a new receptor for β-glucans. Nature 413: 36-37.
9. Patriotis, C., A. Makris, S. E. Bear, and P. N. Tsichlis. 1993. Tumor progression locus 2 (Tpl-2) encodes a protein kinase involved in the progression of rodent T-cell lymphomas and in T-cell activation. Proc. Natl. Acad. Sci. USA 90: 2251-2255.
10. Erny, K. M., J. Peli, J. F. Lambert, V. Muller, and H. Diggelmann. 1996. Involvement of the Tpl-2/cot oncogene in MMTV tumorigenesis. Oncogene 13: 2015-2020.
11. Ceci, J. D., C. P. Patriotis, C. Tsatsanis, A. M. Makris, R. Kovatch, D. A. Swing, N. A. Jenkins, P. N. Tsichlis, and N. G. Copeland. 1997. Tpl-2 is an oncogenic kinase that is activated by carboxy-terminal truncation. Genes Dev. 11: 688-700.
12. Waterfield, M. R., M. Zhang, L. P. Norman, and S. C. Sun. 2003. NF-κB1/p105 regulates lipopolysaccharide-stimulated MAP kinase signaling by governing the stability and function of the Tpl2 kinase. Mol. Cell 11: 685-694.
13. Dumitru, C. D., J. D. Ceci, C. Tsatsanis, D. Kontoyiannis, K. Stamatakis, J. H. Lin, C. Patriotis, N. A. Jenkins, N. G. Copeland, G. Kollias, and P. N. Tsichlis. 2000. TNF-α induction by LPS is regulated posttranscriptionally via a Tpl2/ERK-dependent pathway. Cell 103: 1071-1083.
14. Sugimoto, K., M. Ohata, J. Miyoshi, H. Ishizaki, N. Tsuboi, A. Masuda, Y. Yoshikai, M. Takamoto, K. Sugane, S. Matsuo, Y. Shimada, and T. Matsuguchi. 2004. A serine/threonine kinase, Cot/Tpl2, modulates bacterial DNA-induced IL-12 production and Th cell differentiation. J. Clin. Invest. 114: 857-866.
15. Rousseau, S., M. Papoutsopoulou, A. Symons, D. Cook, J. M. Lucocq, A. R. Prescott, A. O'Garra, S. C. Ley, and P. Cohen. 2008. TPL2-mediated activation of ERK1 and ERK2 regulates the processing of pre-TNF α in LPS-stimulated macrophages. J. Cell Sci. 121: 149-154. (Pubitemid 351228446)
16. Watford, W. T., B. D. Hissong, L. R. Durant, H. Yamane, L. M. Muul, Y. Kanno, C. M. Tato, H. L. Ramos, A. E. Berger, L. Mielke, et al. 2008. Tpl2 kinase regulates T cell interferon-γ production and host resistance to Toxoplasma gondii. J. Exp. Med. 205: 2803-2812.
17. Banerjee, A., R. Gugasyan, M. McMahon, and S. Gerondakis. 2006. Diverse Toll-like receptors utilize Tpl2 to activate extracellular signal-regulated kinase (ERK) in hemopoietic cells. Proc. Natl. Acad. Sci. USA 103: 3274-3279.
18. Corr, S. C., and L. A. O'Neill. 2009. Listeria monocytogenes infection in the face of innate immunity. Cell Microbiol. 11: 703-709.
19. Pamer, E. G. 2004. Immune responses to Listeria monocytogenes. Nat. Rev. Immunol. 4: 812-823.
20. Hunter, C. A., A. Villarino, D. Artis, and P. Scott. 2004. The role of IL-27 in the development of T-cell responses during parasitic infections. Immunol. Rev. 202: 106-114.
21. Gaddi, P. J., and G. S. Yap. 2007. Cytokine regulation of immunopathology in toxoplasmosis. Immunol. Cell Biol. 85: 155-159.
22. Das, S., J. Cho, I. Lambertz, M. A. Kelliher, A. G. Eliopoulos, K. Du, and P. N. Tsichlis. 2005. Tpl2/cot signals activate ERK, JNK, and NF-κB in a celltype and stimulus-specific manner. J. Biol. Chem. 280: 23748-23757.
23. Serbina, N. V., T. P. Salazar-Mather, C. A. Biron, W. A. Kuziel, and E. G. Pamer. 2003. TNF/iNOS-producing dendritic cells mediate innate immune defense against bacterial infection. Immunity 19: 59-70.
24. Underhill, D. M., A. Ozinsky, A. M. Hajjar, A. Stevens, C. B. Wilson, M. Bassetti, and A. Aderem. 1999. The Toll-like receptor 2 is recruited to macrophage phagosomes and discriminates between pathogens. Nature 401: 811-815. (Pubitemid 129515844)
25. Sato, M., H. Sano, D. Iwaki, K. Kudo, M. Konishi, H. Takahashi, T. Takahashi, H. Imaizumi, Y. Asai, and Y. Kuroki. 2003. Direct binding of Toll-like receptor 2 to zymosan, and zymosan-induced NF-κB activation and TNF-α secretion are down-regulated by lung collectin surfactant protein A. J. Immunol. 171: 417-425.
26. Mariathasan, S., D. S. Weiss, K. Newton, J. McBride, K. O'Rourke, M. Roose-Girma, W. P. Lee, Y. Weinrauch, D. M. Monack, and V. M. Dixit. 2006. Cryopyrin activates the inflammasome in response to toxins and ATP. Nature 440: 228-232.
27. Rogers, N. C., E. C. Slack, A. D. Edwards, M. A. Nolte, O. Schulz, E. Schweighoffer, D. L. Williams, S. Gordon, V. L. Tybulewicz, G. D. Brown, and C. Reis e Sousa. 2005. Syk-dependent cytokine induction by Dectin-1 reveals a novel pattern recognition pathway for C type lectins. Immunity 22: 507-517.
28. Underhill, D. M., E. Rossnagle, C. A. Lowell, and R. M. Simmons. 2005. Dectin-1 activates Syk tyrosine kinase in a dynamic subset of macrophages for reactive oxygen production. Blood 106: 2543-2550.
29. Fuller, G. L., J. A. Williams, M. G. Tomlinson, J. A. Eble, S. L. Hanna, S. Pohlmann, K. Suzuki-Inoue, Y. Ozaki, S. P. Watson, and A. C. Pearce. 2007. The C-type lectin receptors CLEC-2 and Dectin-1, but not DC-SIGN, signal via a novel YXXL-dependent signaling cascade. J. Biol. Chem. 282: 12397-12409.
30. Slack, E. C., M. J. Robinson, P. Hernanz-Falcon, G. D. Brown, D. L. Williams, E. Schweighoffer, V. L. Tybulewicz, and C. Reis e Sousa. 2007. Syk-dependent ERK activation regulates IL-2 and IL-10 production by DC stimulated with zymosan. Eur. J. Immunol. 37: 1600-1612.
31. Adachi, Y., T. Ishii, Y. Ikeda, A. Hoshino, H. Tamura, J. Aketagawa, S. Tanaka, and N. Ohno. 2004. Characterization of β-glucan recognition site on C-type lectin, dectin 1. Infect. Immun. 72: 4159-4171.
32. Brown, G. D., J. Herre, D. L. Williams, J. A. Willment, A. S. Marshall, and S. Gordon. 2003. Dectin-1 mediates the biological effects of β-glucans. J. Exp. Med. 197: 1119-1124.
33. Abram, C. L., and C. A. Lowell. 2007. The expanding role for ITAM-based signaling pathways in immune cells. Sci STKE 2007: re2.
34. Gringhuis, S. I., J. den Dunnen, M. Litjens, M. van der Vlist, B. Wevers, S. C. Bruijns, and T. B. Geijtenbeek. 2009. Dectin-1 directs T helper cell differentiation by controlling noncanonical NF-κB activation through Raf-1 and Syk. Nat. Immunol. 10: 203-213.
35. Papoutsopoulou, S., A. Symons, T. Tharmalingham, M. P. Belich, F. Kaiser, D. Kioussis, A. O'Garra, V. Tybulewicz, and S. C. Ley. 2006. ABIN-2 is required for optimal activation of Erk MAP kinase in innate immune responses. Nat. Immunol. 7: 606-615.
36. Dunne, A., and L. A. O'Neill. 2003. The interleukin-1 receptor/Toll-like receptor superfamily: signal transduction during inflammation and host defense. Sci STKE 2003: re3.
37. Deckert, M., S. Virna, M. Sakowicz-Burkiewicz, S. Lutjen, S. Soltek, H. Bluethmann, and D. Schluter. 2007. Interleukin-1 receptor type 1 is essential for control of cerebral but not systemic listeriosis. Am. J. Pathol. 170: 990-1002.
38. Glaccum, M. B., K. L. Stocking, K. Charrier, J. L. Smith, C. R. Willis, C. Maliszewski, D. J. Livingston, J. J. Peschon, and P. J. Morrissey. 1997. Phenotypic and functional characterization of mice that lack the type I receptor for IL-1. J. Immunol. 159: 3364-3371.
39. Havell, E. A., L. L. Moldawer, D. Helfgott, P. L. Kilian, and P. B. Sehgal. 1992. Type I IL-1 receptor blockade exacerbates murine listeriosis. J. Immunol. 148: 1486-1492.
40. Labow, M., D. Shuster, M. Zetterstrom, P. Nunes, R. Terry, E. B. Cullinan, T. Bartfai, C. Solorzano, L. L. Moldawer, R. Chizzonite, and K. W. McIntyre. 1997. Absence of IL-1 signaling and reduced inflammatory response in IL-1 type I receptor-deficient mice. J. Immunol. 159: 2452-2461.
41. Rogers, H. W., C. S. Tripp, R. D. Schreiber, and E. R. Unanue. 1994. Endogenous IL-1 is required for neutrophil recruitment and macrophage activation during murine listeriosis. J. Immunol. 153: 2093-2101.
42. Mariathasan, S. 2007. ASC, Ipaf and Cryopyrin/Nalp3: bona fide intracellular adapters of the caspase-1 inflammasome. Microbes Infect. 9: 664-671.
43. Petrilli, V., C. Dostert, D. A. Muruve, and J. Tschopp. 2007. The inflammasome: a danger sensing complex triggering innate immunity. Curr. Opin. Immunol. 19: 615-622.
44. Seong, S. Y., and P. Matzinger. 2004. Hydrophobicity: an ancient damage-associated molecular pattern that initiates innate immune responses. Nat. Rev. Immunol. 4: 469-478.
45. Skinner, S. J., K. M. Deleault, R. Fecteau, and S. A. Brooks. 2008. Extracellular signal-regulated kinase regulation of tumor necrosis factor-α mRNA nucleocytoplasmic transport requires TAP-NxT1 binding and the AU-rich element. J. Biol. Chem. 283: 3191-3199.
46. Maggi, L. B., Jr., J. M. Moran, R. M. Buller, and J. A. Corbett. 2003. ERK activation is required for double-stranded RNA- and virus-induced interleukin-1 expression by macrophages. J. Biol. Chem. 278: 16683-16689.
47. Rothe, J., W. Lesslauer, H. Lotscher, Y. Lang, P. Koebel, F. Kontgen, A. Althage, R. Zinkernagel, M. Steinmetz, and H. Bluethmann. 1993. Mice lacking the tumour necrosis factor receptor 1 are resistant to TNF-mediated toxicity but highly susceptible to infection by Listeria monocytogenes. Nature 364: 798-802.
48. Wong, M., D. Ziring, Y. Korin, S. Desai, S. Kim, J. Lin, D. Gjertson, J. Braun, E. Reed, and R. R. Singh. 2008. TNFα blockade in human diseases: mechanisms and future directions. Clin. Immunol. 126: 121-136.
49. Green, N., Y. Hu, K. Janz, H. Q. Li, N. Kaila, S. Guler, J. Thomason, D. Joseph-McCarthy, S. Y. Tam, R. Hotchandani, et al. 2007. Inhibitors of tumor progression loci-2 (Tpl2) kinase and tumor necrosis factor α (TNF-α) production: selectivity and in vivo antiinflammatory activity of novel 8-substituted-4-anilino-6-aminoquinoline-3-carbonitriles. J. Med. Chem. 50: 4728-4745.
50. Gavrin, L. K., N. Green, Y. Hu, K. Janz, N. Kaila, H. Q. Li, S. Y. Tam, J. R. Thomason, A. Gopalsamy, G. Ciszewski, et al. 2005. Inhibition of Tpl2 kinase and TNF-α production with 1,7-naphthyridine-3-carbonitriles: synthesis and structure-activity relationships. Bioorg. Med. Chem. Lett. 15: 5288-5292.
51. Hall, J. P., Y. Kurdi, S. Hsu, J. Cuozzo, J. Liu, J. B. Telliez, K. J. Seidl, A. Winkler, Y. Hu, N. Green, et al. 2007. Pharmacologic inhibition of tpl2 blocks inflammatory responses in primary human monocytes, synoviocytes, and blood. J. Biol. Chem. 282: 33295-33304.
52. Hu, Y., N. Green, L. K. Gavrin, K. Janz, N. Kaila, H. Q. Li, J. R. Thomason, J. W. Cuozzo, J. P. Hall, S. Hsu, et al. 2006. Inhibition of Tpl2 kinase and TNFα production with quinoline-3-carbonitriles for the treatment of rheumatoid arthritis. Bioorg. Med. Chem. Lett. 16: 6067-6072.
53. Kaila, N., N. Green, H. Q. Li, Y. Hu, K. Janz, L. K. Gavrin, J. Thomason, S. Tam, D. Powell, J. Cuozzo, et al. 2007. Identification of a novel class of selective Tpl2 kinase inhibitors: 4-Alkylamino-[1,7]naphthyridine-3- carbonitriles. Bioorg. Med. Chem. 15: 6425-6442.
54. Kontoyiannis, D., M. Pasparakis, T. T. Pizarro, F. Cominelli, and G. Kollias. 1999. Impaired on/off regulation of TNF biosynthesis in mice lacking TNF AU-rich elements: implications for joint and gut-associated immunopathologies. Immunity 10: 387-398. (Pubitemid 29165293)
55. Kontoyiannis, D., G. Boulougouris, M. Manoloukos, M. Armaka, M. Apostolaki, T. Pizarro, A. Kotlyarov, I. Forster, R. Flavell, M. Gaestel, et al. 2002. Genetic dissection of the cellular pathways and signaling mechanisms in modeled tumor necrosis factor-induced Crohn's-like inflammatory bowel disease. J. Exp. Med. 196: 1563-1574.
56. Kobayashi, K. S., M. Chamaillard, Y. Ogura, O. Henegariu, N. Inohara, G. Nunez, and R. A. Flavell. 2005. Nod2-dependent regulation of innate and adaptive immunity in the intestinal tract. Science 307: 731-734.
57. Church, L. D., G. P. Cook, and M. F. McDermott. 2008. Primer: inflammasomes and interleukin 1β in inflammatory disorders. Nat. Clin. Pract. Rheumatol. 4: 34-42.
58. Ehses, J. A., M. Boni-Schnetzler, M. Faulenbach, and M. Y. Donath. 2008. Macrophages, cytokines and β-cell death in Type 2 diabetes. Biochem. Soc. Trans. 36: 340-342.
59. Farasat, S., I. Aksentijevich, and J. R. Toro. 2008. Autoinflammatory diseases: clinical and genetic advances. Arch. Dermatol. 144: 392-402.
60. Larsen, C. M., M. Faulenbach, A. Vaag, A. Volund, J. A. Ehses, B. Seifert, T. Mandrup-Poulsen, and M. Y. Donath. 2007. Interleukin-1-receptor antagonist in type 2 diabetes mellitus. N. Engl. J. Med. 356: 1517-1526.